The vesicular monoamine transporter: From chromaffin granule to brain

Neurochemistry International

Volumn 32, Issue 3, 1998, Pages 227-246

  Henry, Jean Pierre ^a   Sagné, Corinne ^a   Bedet, Cécile ^a   Gasnier, Bruno ^a  

^a INST DE BIOLOGIE PHYSICO CHIMIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE DERIVATIVE; CARRIER PROTEIN; MONOAMINE; RECOMBINANT DNA; TETRABENAZINE;

ADRENAL MEDULLA; AMINO ACID TRANSPORT; BIOCHEMISTRY; BIOPHYSICS; BRAIN DEVELOPMENT; CATECHOLAMINE NERVE CELL; CATTLE; CHROMAFFIN GRANULE; GENE EXPRESSION; IMAGING; MOLECULAR CLONING; MONOAMINE NERVE CELL; NEUROSECRETORY CELL; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; SEROTONINERGIC NERVE CELL;

BOS TAURUS; BOVINAE;

EID: 0032033189     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00092-2     Document Type: Article

References (174)

1. Adamson, C. R., Emley, T. E., Herbig, L. J., & Near, J. A. (1997). Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells. Neurochem. Int., 30, 411-415.
2. Amara, S. G., & Arriza, J. L. (1993). Neurotransmitter transporters: three distinct gene families. Curr. Opin. Neurobiol., 3, 337-344.
3. Amara, S. G., & Kuhar, M. J. (1993). Neurotransmitter transporters - Recent progress. Ann. Rev. Neurosci., 16, 73-93.
4. Annaert, W. G., Llona, I., Backer, A. C., Jacob, W. A., & de Potter. W. P. (1993). Catecholamines are present in a synaptic-like microvesicle enriched fraction from bovine adrenal medulla. J. Neurochem., 60, 1746-1754.
5. Apps, D. K., Pryde, J. G., & Phillips, J. H. (1980). Both the transmembrane pH gradient and the membrane potential are important in the accumulation of amines by resealed chromaffin-granule "ghosts". FEBS Lett., 111, 386-390.
6. Aranda, G., Beaucourt, J. P., Ponchant, M., Isambert, M. F., & Henry, J. P. (1990). Synthesis and biological activity of iodinated and photosensitive derivatives of tetrabenazine. Eur. J. Med. Chem., 25. 369-374.
7. Bauerfeind, R., Jelinek, R., Hellwig, A., & Huttner, W. B. (1995). Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granules. Proc. Natl. Acad. Sci. USA, 92, 7342-7346.
8. Bauerfeind, R., Regnier-Vigouroux, A., Flatmark, T., & Huttner, W. B. (1993). Selective storage of acetylcholine, but not catecholamines. in neuroendocrine synaptic-like microvesicles of early endosomal origin. Neuron, 11, 105-121.
9. +) coupled gamma-aminobutyric acid transporter from rat brain. J. Biol. Chem., 272, 1203-1210.
10. Betz, W. J., & Bewick, G. S. (1992). Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science. 255, 200-203.
11. +4 -ATP-dependent storage mechanism in the amine granules of the adrenal medulla. Acta Physiol. Scand. (Suppl.). 215. 1-38.
12. Carlsson, A. (1965). Drugs which block the storage of 5-hydroxytryptamine and related amines. Handbk. Exp. Pharmacol., 19, 529-592.
13. Carlsson, A., & Lindqvist, M. (1966). The interference of tetrabenazine. benzquinamide and prenylamine with the action of reserpine. Acta Pharmacol. Toxicol., 24, 112-120.
14. Chaplin, L., Cohen, A. H., Huetl, P., Kennedy, M., Njus D., & Temperley, S. J. (1985). Reserpic acid as an inhibitor of norepinephrine transport into chromaffin vesicle "ghosts". J. Biol. Chem., 259, 10907-10912.
15. Cidon, S., & Nelson, N. (1983). A novel ATPase in the chromaffin granule membrane. J. Biol. Chem., 258, 2892-2898.
16. Ciolkowski, E. L., Cooper, B. R., Jankowski, J. A., Jorgenson, J. W., & Wightman, R. M. (1992). Direct observation of epinephrine and norepinephrine cosecretion from individual adrenal medullary chromaffin cells. J. Am. Chem. Soc., 114, 2815-2821.
17. Coupland, R. E. (1984). Ultrastructural features of the mammahan adrenal medulla. In: Ultrastructure of endocrine cells and tissues, ed. P. M. Motta, pp. 168-179. Martinus Nijhoff. The Hague.
18. 11C] tetrabenazine to vesicular monoamine transporters in mouse brain. Life Sci., 51, 593-600.
19. 11C] tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies. Appl. Radiat. Isot., 44, 673-676.
20. 11C]tetrabenazine. Synapse, 14, 128-131.
21. Daniels, A. J., & Reinhard, J. F., Jr, (1988). Energy-driven uptake of the neurotoxin l-methyl-4-phenylpyridinium into chromaffin granules v a the catecholamine transporter. J. Biol. Chem., 263, 5034-5036.
22. Darchen, F., Scherman, D., Desnos, C., & Henry, J. P. (1988a). Characteristics of the transport of the quaternary ammonium l-methyl-4-phenylpyndinium by chromaffin granules. Biochetit. Pharmacol., 37, 4381-4387.
23. Darchen, F., Scherman, D., Laduron, P. M., & Henry, J. P. (1988b). Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. Mol. Pharmacol., 33, 672-677.
24. Darchen, F., Scherman, D., & Henry, J. P. (1989). Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry, 28, 1692-1697.
25. De Potter, W. P., & Chubb, I. W. (1977). Biochemical observations on the formation of small noradrenergic vesicles in the splanchnic nerve of the dog. Neuroscience, 2, 167-174.
26. Desnos, C., Laran, M. P., & Scherman, D. (1992). Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus biosynthesis coupling. J. Neurochem., 59, 2105-2112.
27. Desnos, C., Clift-O'Grady, L., & Kelly, R. B. (1995a). Biogenesis of synaptic vesicles in vitro. J. Cell Biol., 130, 1041-1049.
28. Desnos, C., Laran, M. P., Langley, K., Aunis, D. & Henry, J. P. (1995b). Long term stimulation changes the vesicular monoamine transporter of chromaffin granules. Biol. Chem., 270, 16030-16038.
29. 3H]reserpine. J. Biol. Chem., 259, 109017-10912.
30. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85, 5274-5278.
31. Erickson, J. D., Eiden, L. E., & Huffman, B. J. (1992). Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA, 89, 10993-10997.
32. Erickson, J. D., & Eiden, L. E. (1993). Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem., 61, 2314-2317.
33. Erickson, J. D., Varoqui, H., Schafer, M. K. H., Modi, W., Diebler, M. F., Weihe, E., Rand, J., Eiden, L. E., Bonnei, T. I., & Usdin. T. B. (1994). Functional identification of a vesicular acelylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem., 269, 21929-21932.
34. Erickson, J. D., Schäfer, M. K. H., Bonner, T. L. Eiden, L. E., & Weihe, E. (1996). Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA, 93, 5166-5171.
35. Erickson, J. D. (1998). A chimeric monoamine transporter dissociates sensitivity to tetrabenazineand unsuhstituted aromatic amines. Adv. Pharmacol., 42, 227-232.
36. Finnegan, J. M., Pihel, K., Cahill, P. S., Huang, L., Zerby, S. E., Ewing, A. G., Kennedy, R. T., & Wightman, R. M. (1996). Vesicular quantal size measured by amperometry at chromaffin, mast, pheochromocyloma and pancreatic β-cells. J. Neurochem., 66. 1914-1923.
37. Floor, E., Leventhal, P. S., Wang, Y., Meng, L., & Chen, W. (1995). Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J. Neurochem., 64, 689-699.
38. Frey, K. A., Koeppe, R. A., Kilbourn, M. R., Vander Borght, T. M., Albin, R. L., Gilman, S., & Kühl, D. E. (1996). Presynaptic monoaminergic vesicles in Parkinson's disease and normal ageing. Ann. Neurol., 40, 873-887.
39. Fukami, M. H., Holsen, H., & Ugurbil, K. (1984). Histainme uptake in pig platelets and isolated dense granules. Biochem. Pharmacol., 33, 3869-3874.
40. Gasnier, B., Scherman, D., & Henry, J. P. (1985). Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane. Biochemistry 24, 1239-1244.
41. Gasnier, B., Roisin, M. P., Scherman, D., Coornaert, S., Desplanches, G., & Henry, J. P. (1986). Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol. Pharmacol., 29, 275-280.
42. Gasnier, B., Scherrmin, D., & Henry, J. P. (1987). Inactivation of the catecholamine transporter during the preparation of chromaffin granule membrane "ghosts". FEBS Lett., 222, 215-219.
43. Gasnier, B., Krejci, E., Bottom, D., Massoulié, J., & Henry, J. P. (1994). Expression of a bovine vesicular monoamine transporter in COS cells. FEBS Lett., 342, 225-229.
44. Gilman, S., Frey, K. A., Koeppe, R. A., Junck, L., Little, R., Vander Borght, T. M., Lohman, M., Martorello, S., Lee, L. C., Jewett, D. M., & Kilbourn, M. R. (1996). Decreased striatal monoaminergic terminals in olivoponto-cerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Ann. Neurol. 40, 885-892.
45. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
46. Henry, J. P., & Scherman, D. (1989). Radioligands of the vesicular monoamme transporter and their use as markers of monoamine storage vesicles. Biochem. Pharniacol., 38, 2395-2404.
47. Henry, J. P., Botton, D., Sagne, C., Isambert, M. F., Desnos, C., Blarichard, V., Raisman-Vozari, R., Krejci, F., Massoulié, J., & Gasnier, B. (1994). Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J. Exp. Biol., 196, 250-262.
48. Henry, J. P., Sagné, C., Botton, D., Isambert, M. F., and Gasnier, B (1998). Molecular pharmacology of the vesicular monoamine transporter. Adv. Pharmacol., 42, 236-239.
49. Howell, M., Shirvan, A., Sternbach, Y., Steiner-Mordoch, S., Strasser, J. E., Dean, G. E., & Sehuldiner, S. (1994). Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett., 338, 16-22.
50. Hunter, A., Waldron, K., & Apps, D. K. (1982). Determination of the proportion of sealed vesicles in a preparation of chromaffin granule membrane "ghosts". FEBS Lett., 144, 51-56.
51. Isambert, M. F., & Henry, J. P. (1981). Effect of diethylpyrocarbonate on pH-driven monoamine uptake by chromaffin granule ghosts. FEBS Lett., 136, 13-18.
52. Isambert, M. F., & Henry, J. P. (1985). Photoaffinity labeling of the tetrabenazine binding sites of bovine chromaffin granule membranes. Biochemistry, 24, 3660-3667.
53. 125I]iodoketanserin. Biochemistry, 2*. 2265-2270.
54. Isambert, M. F., Gasnier, B., Botton, D., & Henry, J. P. (1992). Characterization and purification of the monoamine transporter of bovine chromaffin granules. Biochemistry, 31, 1980-1986.
55. Jacque, S. Jr., Tobes, M. C., Sisson, J. C., Baker, J. A., & Wieland, D. M. (1984). Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepincphrine into cultured bovine adrenomedullary cells. Mol. Pharmacol., 26, 539-546.
56. 14C]dihydrotetrabenazine (DTBZ). Nucl. Med. Biol., 24. 197-199.
57. Johnson, R. G., & Scarpa, A. (1976). Ion permeability of isolated chromaffin granules. J. Gen. Physiol., 68, 601-631.
58. Johnson, R. G., Carly, S. E., & Scarpa, A. (1981). Proton: substrate stoechiometry during active transport of biogenic amines in chromaffin ghosts. J. Biol. Chem., 256, 5773-5780.
59. Johnson, R. G. (1988). Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev., 68, 232-307.
60. Kanner, B. I., Sharon, I., Maron, R., & Sehuldiner, S. (1980). Electrogenic transport of biogenic amines in chromaffin granule membrane vesicles. FEBS Lett., 111, 83-86.
61. Kanner, B. I., & Schuldiner, S. (1987). Mechanism of storage and transport of neurotransmitters. CRC Crit. Rev. Biochem., 22, 1-38.
62. 11C]tetrabenazine and positron omission tomography. J. Neurochem., 60, 2315-2318.
63. Kilbourn, M. R., Lee, L., Vander Borght, T. V., Jewett, D., & Frey, K. (1995). Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur. J. Pharmacol., 278, 249-252.
64. Kilbourn, M. R., Frey, K. A., Vander Borght, T., & Sherman, P. S. (1996). Effect of dopaminerga drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl. Med. Biol., 23, 467-471.
65. Kilbourn, M. R., Lee, L. C., Heeg, M. J., Jewett, D. M. ( 1997). Absolute configuration of (+) alpha-dihydrotetrabenazine, an active metabolite of tetrabenazine. Chirality, 9, 59-62.
66. Kirshner, N. ( 1962). Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem., 237, 2311-2317.
67. +: uptake and toxicity in non-neuronal COS cells expressing dopamitif transporter cDNA. 4nu. Nenrol., 32, 109-111.
68. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., & Uhl, G. R. (1992b). Dopamine transporter site-directed mutations differently alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA, 89, 7782-7785.
69. Klein, R. L. (1982). Chemical composition of large noradrenergic vesicles. In: Neurotransmitter resides, eds R. L. Klein, H. Lagercrantz and H. Zimmerman, pp. 133-174. Academic Press. London.
70. Klein, R. L., & Lagererantz, H. (1982). Insights into the functional role of the noradrenergic vesicles. In: Neurotransmitter resides, eds R. L. Klein, H. Lagererantz and H. Zimmerman, pp. 219-259. Academic Press. London.
71. +-linked dopamine transport on chromaffin granule ghosts. Biochemistry, 20, 6625-6629.
72. Kjioth, J., Peabody, J. O., Huetl, P., & Njus, D. (1984). Kinetics of tyramine transport and permeation across chromaffin vesicle membrane. Biochemistry, 23, 2011-2016.
73. 11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Cereb. Blood Flow Metab., 16, 1288-1299.
74. Krantz, D. E., Peter, D., Liu, Y., & Edwards, R. H. (1997). Phosphorylation of a vesicular monoamine transporter by casein kinase II. J. Bioi. Chem., 272, 6752-6789.
75. Krejci, E., Gasnier, B., Botton, D., Isambert, M. F., Sagné C., Gagnon, J., Massoulié. J., & Henry, J. P (1993). Expression and regulation of the bovine vesicular monournine transporter gene FEBS Lett., 335, 27-32.
76. 125I-iodovinyltetrabenazine binding to CNS vesicular monoamine transport sites. Synapse, 18, 225-232
77. Laslop, A., Mahata, S. K., Wolkersdorfer, M., Mahata, M., Srivastava, M, Seidah, N. C., Fischer-Colbrie, R., & Winkler, H. (1994). Large dense-core vesicles in rat adrenal after reserpine: levels of mRNAs of soluble and membrane-bound constituents in chromaffin and ganglion cells indicate a biosynthesis of vesicles with higher secretory quanta. J. Neurochem., 62, 2448-2456.
78. Lee, L. C., Vander Borght, T., Sherman, P. S., Frey, K. A. & Kilbourn, M. R. (1996). In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporier. J. Med. Chem., 39, 191-196.
79. +. J. Neural Transm. [GenSect], 93, 75-82.
80. 3H-ligand for serotonin 2-receptor binding site, Mol. Pharmacol., 21, 301-314.
81. Liu, Y., Roghani, A., & Edwards, R. H. (1992a). Gene-transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA. 89, 9074-9078.
82. + toxicity encodes a vesicular amine transporter. Cell. 70, 539-551.
83. Liu, Y., Schweitzer, E. R., Nirenberg, M. J., Pickel, V. M., Evans, C. J., & Edwards, R. H. (1994). Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J. Cell Biol., 127, 1419-1433.
84. Ludowyke, R. I., & Lagunoff, D. L. (1986). Amine uptake into intact mast cell granules in vitvo. Biochemistry, 25, 6287-6293.
85. Mahata, S. K., Mahata, M., Fischer-Colbrie, R., & Winkler, H. (1993a). Vesicle monoamine transporters 1 and 2 differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla. Neuroscience Lett., 156, 70-72.
86. Mahata, S. K., Mahata, M., Fischer-Colbrie, R., & Winkler, H. (1993b). Reserpine causes differential changes in the mRNA levels of chromogranin B, secretogranin II, alpha amidating monooxygenase, the vesicular monoamine transporter and of synaptin/ synaptophysin in rat brain. Mol. Brain Res., 19, 83-92.
87. Maron, R., Stern, Y., Kanner, B., & Schuldiner, S. (1983). Functional asymmetry of the amine transporter from chromaffin granules. J. Biol. Chem., 258, 11476-11481.
88. 3H]Dihydrotetrabenazine, a new marker for the visualization of dopamirieigic denervation in the rat striatum. Neurosci. Lett., 114, 45-50.
89. Merickel, A., & Edwards, R. H. (1995). Transport of histamine by vesicular monoamine transporter-2. Neuropharmalogy, 34, 1543-1547.
90. Merickel A., Rosandich, P., Peter, D., & Edwards, R. H. (1995). Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J. Biol Chew., 270, 25798-25804.
91. Merickel A., Kaback, H. R., & Edwards, R. H. (1997). Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition. J. Biol. Chem., 272, 5403-5408.
92. 3H]dihydrotetrabenazine binding in bovine striatal subsynaptic fractions: enrichment of higher affinity binding in a sytiaptic vesicle fraction. Neurochem., 50, 824-830.
93. Mitchell, P. (1961). Coupling ofphosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature, 191, 144-146.
94. Moriyama, Y., Yamamoto, A., Yamada, H., Tashiro, Y., Tomochika, K. I., Takahashi, M., Maeda, M., & Futai, M. (1995). Microvesicles isolated from bovine posterior pituitary accumulate norepinephrine. J. Biol. Chem., 270, 11424-11429.
95. Moriyama, Y., Yamamoto, A., Yamada, H., Tashiro, Y., & Futai, M. (1996). Role of endocrine cell microvesicles in intercellular chemical trarisduction, Biol. Chem. Hoppe-Seyfer. 377, 155-165.
96. Nakanishi, N., Onozavva, S., Matsumolo, R., Kurihara, K., Ueha, T., Hasegavva, H., & Minami, N. (1995a). Effects of protein kinase inhibitors and prolein phosphatase inhibitors in pheochromocyloma PC12 cells. FEBS Lett., 368, 411-414.
97. Nakanishi, N., Onozawa, S., Matsumoto, R., Hasegawa, H., & Yamada, S. (1995b). Cyclic AMP-dependcnt modulation of vesicular monoamine transporter in pheocromocytoma cells J. Neurochem., 64, 600-607.
98. Navone, F., Jahn, R., Di Goia, G., Stukenbrok, H., Greengard, P., & De Camilli, P. (1986). Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J. Cell Biol., 103, 2511-2527.
99. Neal, R. J., & Chater, K. F. (1987). Nucleotide sequence analysis reveals similarities between proteins determining methylenomycin A resistance in streptomyces and tetracycline resistance in eubacteria. Gene, 58, 229-241.
100. 3H]Dihydroletrabenazine binding to bovine striatal synaptic vesicles. Mol. Pharmacol., 30, 252-257.
101. +-ATPases. J. Bioenerg. Biomembr., 21, 553 572.
102. + -ATPase, one of the most fundamental ion pumps in nature., /. Exp. Biol., 172, 19-27.
103. Neyfakh, A. A., Bidnenko, V. E., & Chen, L. B. (1991). Efflux-mediated multidrug resistance in Bacillus suhtilis: similarities and dissimilarities with the mammalian system, Proc. Natl. Acad. Sci. USA, 88, 4781-4785.
104. Nguyen, T. T , Postle, K., & Bertrand, K. P. (1983). Sequence homology between the tetracycline-resistance determinants of Tn10 and pBR322. Gene, 25, 83-92.
105. Nirenberg, M. J., Liu, Y., Peter, D., Edwards, R. H. & Pickel, V. M (1995). The vesicular monoaminc transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc. Natl. Acad. Sci. USA. 92. 8773-8777.
106. Nirenberg, M. J. J. C., Liu, Y., Edwards, R. H., & Pickel, V. M. (1997). Vesicular monoamine transporter-2: immunogold localisation in striatal axons and terminals Synapse, 26, 194-198.
107. Njus, D., & Radda, G K. (1978). Bioenergetic processes in chromaffin granules: a new perspective on some old problems, Biochim. Biophys. Acta, 463, 219-244.
108. Njus, D., & Radda, G. K. (1979). A potassium ion diffusion potential causes adrenaline uptake in chromaffin granule ghnsts Biochem. J., 180, 579-585.
109. Njus, D., Kelley, P. M., & Harnadek, G. J. (1986). Bioenergetics of secretory vesicles. Biochim. Biophys. Acta, 853, 237-265.
110. Olivares, L., Aragon, C., Giménez, C., & Zafra, F. (1997). Analysis of the transmembrane topology of the glycine transporter GLYTI. J. Biol. Chem., 272, 1211-1217.
111. Öskan, E. D., Khilnani, A., & Njus, D (1993). Histamine transport by the chromaffin vesicle monoamine transporter, pp. 94. Abstract of the Intern. Sympos. Chromaffin Cell Biology and Pharmacology, Ottawa. Canada.
112. Peter, D., Finn, J., Klisak, L, Lia, Y., Kojis, T., Heinzmann, C., Roghani, A., Sparkes, R., & Edwards, R. H. (1993). Chromosomal localization of the human vesicular ami ne transporter genes. Genomics, 18. 720-723.
113. Peter, D., Jimenez, J., Liu, Y., Kim, J., & Edwards, R. H. (1994). The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Client., 269, 7231-7237.
114. Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brccha, N., & Edwards, R. H. (1995). Differential expression of two vesicular monoamine transporters. J. Neurosciencc, 15, 6179-6188.
115. Peter, D, Vu, T., & Edwards, R. H. (1996). Chimenc vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to teirabenazine J. Biol Chem., 277, 2979-2986.
116. Phillips, J. H. (1974a). Transport of catecholamines by resealed chromaffin granule "ghosts". Biochem. J., 144, 311-318.
117. Phillips, J. H. (1974b), Steady-slate kinetics of catecholamme transport by chromaffin granule ghosts. Biochcm. J., 144, 319 325.
118. Phillips, J. H. (1982). Dynamic aspects of chromaffin granule structure. NeuroxcicHce, 7. 1595 1609.
119. Pifl, C., Drobny, H., Reithcr, M., Hornykiewicz, O., & Singer, E. A. (1995). Mechanism of the dopamine-releasing actions of amphet-aminé and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol., 47, 368-373.
120. Pin, C., Giros, B., & Caron, M. G. (1993). Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonisminducing neurotoxin l-methyl-4-phenylpyridinium.y. Neuroxcience. 13, 4246-4253.
121. Pletscher, A., Brossi, A., & Gey, K. F. (1962). Benzoquinolizine derivatives: a new class of monoamine decreasing drugs with psycholropic action. Inf. Rer. Neurobiol., 4, 275-306.
122. Reinhardt, J F., Jr. Diliberto, E. J., Viveros, O. H., & Daniels, A. J. (1987). Subcellular compartimentali/ation of l-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicily to adrenal chromaffin cells. Proc. Natl. Acad. Sci. 1 USA, 84, 8160-8164.
123. Roghani, A., Feldman, J., Kohan, S. A., Shirzadi, A., Gunderscn, C. B., Brecha, N., & Edwards, R. H, (1994). Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA, 91, 10620-10624.
124. Roisin, M. P., Scherman, D., & Henry, J. P. (1980). Synthesis of ATP by an artificially imposed electrochemical gradient in chromaffin granule ghosts. FEBS Lett., 115, 143-147.
125. Rudnick, G. Steincr-Mordoch, S. S., Fishkes, H., Stern-Bach, Y., & SchuldiniT, S. (1990). Energetics of reserpine binding and occlusion by the chromaffin granule transporter. Biochemistrv. 29, 603-608.
126. Rudnick, G., & Wall, S. C. (1992). The molecular mechanism of "Ecstasy" [3,4-Melhylenedioxymcthamphetamine (MDMA)]: serotonin transporters are targets for M DMA-induced serotonin release. Proc. Natl. Acad. Sci. USA, 89, 1817-1821.
127. Ryan, T. A., Reuter, H., Wendland, B., Schweizer, F. E , Tsien, R. W., & Smith, S. J. (1.993). The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Niuron, 11, 713-724.
128. Sabol, K. E, & Seiden, L. S. (1992). Transporters of delight Curr. Biol., 2, 414-416.
129. Sagné. C., Isambert, M. F , Henry, J. P., & Gasnier, B. (1996). SDS-resislant aggregation of membrane proteins: application to the purification of the monoamine transporter. Biochem. J., 316, 825-831.
130. Sagné. C., lsambert, M F., Vandekerckhove, J., Henry, J. P., & Gasnier, B. (1997). The photoactivatable inhibitor 7-azido-8-iodo-ketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules. Biochemistry, 36. 3345 3352.
131. Sato, K., Adams, R., Betz, H., & Schloss, P. (1995). Modulation of a recombinant glycine transporter (GEYTIb) by activation of protein kinase C. J. Neurochem., 65, 1967-1973.
132. Schcrman, D., & Henry, J. P. (198Oa). Roll-of the proton electrochemical gradient in monoamine transporl by bovine chromaffin granules. Biochim. Biophys. Acta, 601. 664-677.
133. Scherman, D., & Henry, J.-P. (1980b). Effect of drugs on the ATP-induccd and pH gradient-driven monoamines transport by bovine chromaffin granules. Binchem. Pharmacol., 29, 1883-1890.
134. Scherman, D., & Henry, I. P. (1981). pH-dependence of the ATP-dependen; uptake of noradrenaline by bovine chromaffin granule ghosts. Eur. J. Biochem., 116, 535-539.
135. Scherman, D., & Henry, J. P. (1982). Acidobasic properties of the catecholamine uptake inhibitors letrabcnazine and dihydrotetrabenazine. Biochimic., 64, 915-921.
136. Scherman, D., & Henry, J. P. (1983a). The catecholamine carrier of bovine chromaffin granules: form of the bound amine. Mol. Pharmacol. 23. 431-436.
137. Scherman, D., & Henry, J. P. (1983b). Solubilization of the catecholamine carrier of chromaffin granule membrane in a form which binds substrates and inhibitors of uptake. Biochemistry, 22, 2805-2810.
138. 3H]dihydrotetrabenazine. Proc. Natl. Acad. Sci. USA, 80, 584-588.
139. Scherman, D., & Henry, J. P. (1984). Reserpine binding to bovine chromaffin granule membranes: characterization and comparison with dihydrotetrabenazine binding. Mol. Pharmacol., 25, 113-122
140. Scherman, D, (1986). Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J. Neurochem., 47, 331-339.
141. Scherman, D., Boschi, G., Rips, R., & Henry, J, P. (1986). The regionalization of fHjdihydrotetrabenazine binding sites in mouse brain and its relationship to the distribution of monoamines and their metabolites. Brain Res., 370. 176-181.
142. Scherman, D., & Boschi, G. (1988). Time required for transmitter accumulation inside monoamine storage vesicles differs in peripheral and in central systems. Neuroscience. 27, 1029-1035.
143. 3H] Dihydrotelrabenazine. a new in vitro monoaminergic probe for human brain. J. Neurochem., 50, 1131-1136.
144. Scherman, D., Desnos, C., Darchen, F., Pollak, P., Javoy-Agid, F., & Agid, Y. (1989). Striatal dopamine deficiency in Parkinson's disease: role of ageing. Ann. Neurol., 26, 551-557.
145. Schmidt, A., Hannah, M., & Huttner, W. B. (1997). Synaptic-like microvesicies of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor. J. Cell Biol., 137, 445-458.
146. Schuldiner, S., Steiner-Mordoch, S., Yelin, R., Wall, S. C , & Rudnick. C. (1993). Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol., 44, 1227-1231.
147. Schuldiner, S. (1994). A molecular glimpse of vesicular monoamine transporters. Neurochem., 62, 2067-2077.
148. Schuldiner, S., Shirvan, A., & Linial, M. (1995). Vesicular neurotransmitter transporters: from bacteria to humans. Physiol. Rev., 75, 369-392.
149. Shirvan, A., Laskar O., Steiner-Mordoch, S., & Schuldiner, S. (1994). Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat. FEBS Lett., 356, 145-150.
150. Sietzen, M., Schober, M., Fischer-Colbrie, R., Scherman, D., Sperk, G., & Winkler, H. (1987). Rat adrenal medulla levels of chromogranins, enkephalms. dopamine β-hydroxylase and of the amine transporter are regulated by nervous acthily and hypophysectomy. Neuroscience, 22, 131-139.
151. 1 by replacement of aspartate 404 with glutamate. J. Biol Chem., 271 13048-13054.
152. Stern-Bach, Y., Greenberg-Ofrath, N., Flechner, I., & Sohuldiner, S. (1990). Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem., 265, 3961-3966.
153. Stern-Bach, Y., Keen, J. N., Bejerano, M , Steiner-Mordoch, S., Wallach, M., Findlay, J. B. C., & Schuldiner, S. (1992). Homology of a vesicular amine transporter Io a gene conferring resistance to I-methyl-4-phenylpyridiniutn. Proc. Natl. Acad. Sci. USA, 89, 9730-9733.
154. Stitzel, R. E. (1977). The biological fate of reserpine. Pharmacol. Rev. 28, 179-205.
155. Suchi, R., Stern-Bach, Y., Gabay, T . & Schuldiner, S. (1991). Covalent modification of the amine transporter with N,N′-dicydohexylcarbodiimide. Biochemistry, 30, 6490-6494.
156. Suchi, R., Stern-Bach, Y., & Schuldiner, S. (1992). Modification of arginyl or hislidyl groups affects the energy coupling of the amine transporter. Biochemistry, 31, 12500-12503.
157. Sulzer, D., & Rayport, S. (1990). Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron. 5. 797-808.
158. Sulzer, D., Maidment, N. T., & Rayport, S. (1993). Amphetamine and other weak bases act to promote reverse transport of Jopamine in ventral midbrain neurons. J. Neurochem., 60, 527-535
159. Sulzer, D., Pothos, E, N., Sun, B. C., Chen, T. K., Ewmg, A., Liu, Y., & Edwards, R. H. (1996). Modulation of quantal dopamine release by psychostimulants, pp. 196. Abstract 8th Inter. Catecholamine Symposium, Asilomar, Pacific Grove.
160. Surratt, C. K., Persico, A. M., Yang, X. D., Edgar, S. R., Bird, G. S., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., & Uhl, G. R. (1993). A human synaptic vesicle monoamine transporter cDNA predicts posttransLational modifications, reveals chromosome-10 gene localization and identifies TaqI RFLPS. FEBS Lett., 318, 325-330.
161. Takei, K., Mundigl, O., Daniell, L., & De Camilli, P. (1996). The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamm. J. Cell Biol., 133, 1237-1250.
162. Thureson-Klein, A. (1982). Ultrastructural preservation of vesicles in sympathetic nervous tissue. In: Neurotransmitter resicles, eds R. L., Klein, H. Lagercrantz, & H. Zimmerrnan, pp. 65-87. Academic Press, London.
163. Tipton, K. F., & Singer, T. P. (1993). Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem., 61, 1191-1206.
164. Uhl G. R., Walther, D., Masu, D., Faucheux, B., & Javoy-Agid, F. (1994). Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann. Neurol., 35, 494-498.
165. Ungar, A., & Phillips, J. H. (1983). Regulation of the adrenal medulla. Physiol. Rev., 63, 787-843.
166. 3H]Methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neitroscience, 68, 935-962.
167. Valider Borglit, T. M., Kilbourn, M. R., Koeppe, R. A., Da Suva, J. N., Carey, J. E., Kuhl, D. E., & Frey, K. A. (1995b). In vivo imaging of the brain vesicular monoamine transporter. J. Nuclear Med., 36. 2252-2260.
168. Varoqui, H., Diebler, M.-F., Meunier, F.-M., Rand, J. B., Usdin, T. B, Bonner, T. I., Eiden, L. E., & Erickson, J. D. (1994). Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetyleholine transporter UNC-17 from Caenorhabdili.s ek-gans FEBS Lett., 342, 97-102.
169. 3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla. Molec, Pharmacol., 40, 889-894.
170. Weihe, F., Shäfer, M. K. H., Erickson, J. D., & Eiden, L. E. (1995). Eocalization of vesicular monoamine transporter isofbrms (VMAT-1 and VMAT-2) to endocrine cells and neurons in rat. J. Mol. Neuroscience, 5, 149-164.
171. Weihe, E., Tao-Cheng, J. H., Shafer, M. K. H., & Erickson, J. D. (1996). Visualization of the vesicular acetyleholine transporter in cholmergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl. Acad. Sci USA, 93, 3547 3552.
172. Winkler, H. (1977). The biogenesis of adrenal chromtifrm granule granules. Niuroscience, 2, 657-683.
173. Winkler, H., Sietzen, M., & Schober, M. (1986). The life cycle of calecholamine-storing vesicles. Ann. NY Acad. Sci., 493, 3-19.
174. Yelin, R., & Schuldiner, S. (1995). The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett., 377, 201-207.